Drug Shortage Report for TEVA-ELETRIPTAN
Report ID | 116156 |
Drug Identification Number | 02382105 |
Brand name | TEVA-ELETRIPTAN |
Common or Proper name | TEVA-ELETRIPTAN 40MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ELETRIPTAN |
Strength(s) | 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | ppack 6 |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-05-27 |
Estimated end date | 2021-02-28 |
Actual end date | 2021-02-24 |
Shortage status | Resolved |
Updated date | 2021-02-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-05-29 | English | Compare |
v2 | 2020-05-29 | French | Compare |
v3 | 2020-06-25 | English | Compare |
v4 | 2020-06-25 | French | Compare |
v5 | 2020-07-23 | English | Compare |
v6 | 2020-07-23 | French | Compare |
v7 | 2020-09-17 | English | Compare |
v8 | 2020-09-17 | French | Compare |
v9 | 2020-10-15 | English | Compare |
v10 | 2020-10-15 | French | Compare |
v11 | 2020-11-19 | English | Compare |
v12 | 2020-11-19 | French | Compare |
v13 | 2021-01-07 | English | Compare |
v14 | 2021-01-07 | French | Compare |
v15 | 2021-02-25 | English | Compare |
v16 | 2021-02-25 | French | Compare |
Showing 1 to 16 of 16